Synthesis and crystal structure of 7,8-dihydroquinolino[2,3-a]acridine derivatives

Synthetic Communications

Volumn 39, Issue 14, 2009, Pages 2492-2505

  Han, Guang Fan ^a   Wang, Rui Hua ^a   Zhang, Wen Tao ^a   Zhao, Yu Yuan ^a   Xing, Zheng ^a   Dai, Wei ^a  

^a JIANGSU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

5 substituted 1,3 cyclohexanedione; Acridine derivative; Anticancer activity; Crystal structure; Synthesis

Indexed keywords

6,14 DIAMINO 3,4,11,12 TETRAMETHOXY 7 PHENYL 7,8 DIHYDROQUINOLINO[2,3 A]ACRIDINE; 6,14 DIAMINO 3,4,11,12 TETRAMETHOXY 7,7 DIMETHY 7,8 DIHYDROQUINOLINO[2,3 A]ACRIDINE; 6,14 DIAMINO 7 PHENYL 7,8 DIHYDROQUINOLINO[2,3ALPHA]ACRIDINE; 6,14 DIAMINO 7,7 DIMETHY 7,8 DIHYDROQUINOLINO[2,3ALPHA]ACRIDINE; 9 AMINO 3 PHENYL 1,2,3,4 TETRAHYDROACRIDIN 1 ONE; 9 AMINO 3,3 DIMETHY 1,2,3,4 TETRAHYDROACRIDIN 1 ONE; 9 AMINO 6,7 DIMETHOXY 3 PHENYL 1,2,3,4 TETRAHYDROACRIDIN 1 ONE; 9 AMINO 6,7 DIMETHOXY 3,3 DIMETHY 1,2,3,4 TETRAHYDROACRIDIN 1 ONE; ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZONITRILE; N (2 BENZONITRILE) 1,9 DIAMINO 3 PHENYL 1,2,3,4 TETRAHYDROACRIDINE; N (2 BENZONITRILE) 1,9 DIAMINO 3,3 DIMETHY 1,2,3,4 TETRAHYDROACRIDINE; N (4,5 DIMETHOXYBENZO 2 NITRILE) 1,9 DIAMINO 3 PHENYL 1,2,3,4 TETRAHYDROACRIDINE; N (4,5 DIMETHOXYBENZO 2 NITRILE) 1,9 DIAMINO 6,7 DIMETHOXY 3,3 DIMETHYL 1,2,3,4 TETRAHYDROACRIDINE; N (5 PHENYL 3 OXO CYCLOHEXEN 1 YL) 2 AMINO 4,5 DIMETHOXY BENZONITRILE; N (5 PHENYL 3 OXO CYCLOHEXEN 1 YL) 2 AMINO BENZONITRILE; N (5,5 DIMETHY 3 OXO CYCLOHEXEN 1 YL) 2 AMINO 4,5 DIMETHOXYBENZONITRILE; N (5,5 DIMETHY 3 OXO CYCLOHEXEN 1 YL) 2 AMINOBENZONITRILE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYST; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED RADIATION; MASS SPECTROMETRY; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; X RAY DIFFRACTION;

EID: 67650302857     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910802656042     Document Type: Article

References (14)

1. Tanner, D. Chiral aziridines-their synthesis and use in stereoselective transformations. Angew. Chem., Int. Ed. Engl. 1994, 33, 599.
2. Boulanger, C.; Giorgio, C.; Vierling, P. Synthesis of acridine-nuclear localization signal (NLS) conjugates and evaluation of their impact on lipoplex and polyplex-based transfection. Eur. J. Med. Chem. 2005, 40 (12), 1295.
3. Moor, M. J.; Schultes, C. M.; Cuesta, J.; Cuenca, F.; Gunaratnam, M.; Tanious, F. A. Trisubstituted acridines as G-quadruplex telomere targeting agents: Effects of extensions of the 3, 6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J. Med. Chem. 2006, 49(2), 582.
4. Chiron, J.; Galy, J. P. Reactivity of the acridine ring: One-pot regioselective single and double bromomethylation of acridine and some derivatives. Synthesis2004, 3, 313.
5. Tu, S. J.; Wang, Q.; Zhang, Y.; Xu, J. N.; Zhang, J. P.; Zhu, X. T.; Shi, F. J. An efficient one-pot synthesis of N-carboxymethylacridine-1,8- dione derivatives under microwave irradiation. Hererocycl. Chem. 2006, 43 (6), 1647.
6. Shutske, G. M.; Pierrat, F. A.; Kapples, K. J.; Cornfeldt, M. L.; Szewczak, M. R.; Huger, F. P.; Bores, G. M.; Haroutunian, V.; Davis, K. L. 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: Synthesis and evaluation as potential Alzheimer's disease therapeutics. J. Med. Chem. 1989, 32, 1805.
7. Rosini, M.; Antonello, A.; Cavalli, A.; Bolognest, M. L.; Minarint, A.; Marucci, G.; Leonardi, A.; Melchiorre, C. Prazosin-related compounds: Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for a1-adrenoreceptors. J. Med. Chem. 2003, 46, 4895.
8. Dzierzbicka, K.; Kolodziejczyk, A. M.; Wysocka-Skrzela, B.; Mysliwski, A.; Sosnowska, D. Synthesis and antitumor activity of conjugates of muramyldipeptide, normuramyldipeptide, and desmuramylpeptides with acridine= acridone derivatives. J. Med. Chem. 2001, 44, 3606.
9. Dzierzbicka, K.; Kolodziejczyk, A. M. Synthesis and antitumor activity of conjugates of muramyldipeptide or normuramyldipeptide with hydroxyacridine= acridone derivatives. J. Med. Chem. 2003, 46, 183.
10. Ravi, H.; Padma, T.; Mayur, C. Y.; Gowdahalli, K.; Kuntebommanahalli, N. T.; Peter, J. H.; Yerigeri, M. Anti-calmodulin acridone derivatives modulate vinblastine resistance in multidrug resistant (MDR) cancer cells. Eur. J. Med. Chem. 2004, 39, 161.
11. Philippe, B.; Johann, B.; Thomas, G.; Martin, T. Acridine and acridone derivatives, anticancer properties, and synthetic methods: Where are we now? Anti-Cancer Agents Med. Chem. 2007, 7 (2), 139.
12. Laurent, B.; Brigitte, B.; Marie-Paule, H.; Amelie, L.; Marie-Helene, D. C.; Daniele, C.; Alain, C.; Olivier, R.; Martine, D. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine: Synthesis, antitumor activity, and DNA binding. Bioorg. Med. Chem. 2006, 14 (22), 7520.
13. Wainwright, M. J. Acridine-a neglected antibacterial chromophore. Antimicrob. Chemother. 2001, 47 (1), 1.
14. Han, G.-F.; Wang, J.-J.; Jiang, G.-J. Synthesis of chroman4-ono [2,3-b]quinolinone derivative. Chin. J. Org. Chem. 2003, 23 (9), 1004.